Journals / İstanbul Kanuni Sultan Süleyman Tıp Dergisi / 2022 / Cilt: 14 - Sayı: 2

The Role of Imaging Methods and Laboratory Parameters in the Predictionof Malignancy Potential for Adnexal Masses

Adneksiyel Kitlelerde Malignite Potansiyelinin Tahmininde Görüntüleme Yöntemleri ve Laboratuvar Parametrelerinin Yeri

Pages
186–194
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: The parameters that showed significant difference between the two groups were age and chief complaints as clinical features, presence of ascites in USG and/or MRI, solid areas in USG and/or MRI, contrast-enhancement in MRI as radiologic findings, malignancy suspect in the imaging, CA125, CA19–9, CA153, and AFP levels as tumor markers (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of the study was to evaluate the ability of clinical features, ultrasonography (USG), magnetic resonance imaging (MRI), and tumor markers to predict malignity potential in the pre-operative period for adnexal mass cases investigated by intra-operative frozen section.
📊
Key Findings & Data:The patients were divided into two groups as benign (n=160) and malignant (n=55) according to the post-operative histopathologic findings.
💡
Conclusion & Impact:Results: The parameters that showed significant difference between the two groups were age and chief complaints as clinical features, presence of ascites in USG and/or MRI, solid areas in USG and/or MRI, contrast-enhancement in MRI as radiologic findings, malignancy suspect in the imaging, CA125, CA19–9, CA153, and AFP levels as tumor markers (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The aim of the study was to evaluate the ability of clinical features, ultrasonography (USG), magnetic resonance imaging (MRI), and tumor markers to predict malignity potential in the pre-operative period for adnexal mass cases investigated by intra-operative frozen section. Method: The clinical features, USG, MRI, and tumor markers of the adnexal mass cases investigated by intra-operative frozen section were evaluated as potential predictive parameters. The patients were divided into two groups as benign (n=160) and malignant (n=55) according to the post-operative histopathologic findings. Logistic regression analysis was performed for parameters that gave significant differences between the two groups to find the high yield ones (independent variables) for pre-operative malignity potential prediction. Results: The parameters that showed significant difference between the two groups were age and chief complaints as clinical features, presence of ascites in USG and/or MRI, solid areas in USG and/or MRI, contrast-enhancement in MRI as radiologic findings, malignancy suspect in the imaging, CA125, CA19–9, CA153, and AFP levels as tumor markers (p

Özet

Amaç: Çalışmada, adneksiyel kitle tanısı ile opere edilen ve intraoperatif frozen inceleme uygulanan olgularda klinik özellikler, görüntüleme yöntemleri (manyetik rezonans/ultrasonografi) ve laboratuvar parametrelerinin malignite potansiyelini preoperatif öngörme gücünün değerlendirilmesi amaçlandı. Yöntem: Adneksiyel kitle ön tanısı ile intraoperatif frozen inceleme yapılan olgularda klinik özellik, ultrasonografi, manyetik rezonans ve tümör belirteç parametreleri incelendi. Olgular postoperatif histopatolojik inceleme sonuçlarına göre benign (n=169) ve malign (n=55) over tümörü olarak iki gruba ayrıldı. İki grup arasında anlamlı farklılık gösteren parametrelerin lojistik regresyon analizi yapılarak preoperatif malignite potansiyelini öngörmede yüksek güce sahip faktörler araştırıldı. Bulgular: İki grup (benign ve malign histopatoloji) arasında istatistiksel olarak anlamlı farklılık gösteren faktörler; yaş, hastanın semptomları, ultrasonografide assit ve solid alan varlığı, manyetik rezonans görüntülemede; kitlenin kontrast tutulumu, solid alan varlığı, assit varlığı, CA-125, CA 19–9, CA 15–3 ve alfa-fetoprotein düzeyleri değişkenleri anlamlı olarak saptandı (p

🔖

Cite This Article

ÖZYÜREK, Ş. E., KADİROĞULLARI, P., KARACAN, T., KARABÜK, E., KAHRAMAN, E. (2022). The Role of Imaging Methods and Laboratory Parameters in the Predictionof Malignancy Potential for Adnexal Masses. İstanbul Kanuni Sultan Süleyman Tıp Dergisi, Cilt: 14 - Sayı: 2, 186–194. https://ajindex.com/articles/550895

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Jayson GC, Kohn EC, Kitchener HC, Ledermann JA. Ovarian cancer. Lancet 2014;384:1376–88
  2. National Cancer Institute. Ovarian epithelial cancer treatment (PDQ), 2014b. Available at: www.cancer.gov/cancertopics/pdq/treatment/ovarianepithelial/healthprofessional. Accessed Jan 12, 2015
  3. Kuşçu E. Benign ve malign adneksial kitlelerin ayırıcı tanısında tümör belirteçleri, görüntüleme yöntemleri ve doppler değerlendirmenin yeri. TJOD Uzmanlık Sonrası Eğitim Derg 2004;1:85–90
  4. Obiakor I, Maiman M, Mittal K, Awobuluyi M, DiMaio T, Demopoulos R. The accuracy of frozen section in the diagnosis of ovarian neoplasms. Gynecol Oncol 1991;43:61–3
  5. Mutch DG, Prat J. 2014 FIGO staging for ovarian, fallopian tube and peritoneal cancer. Gynecol Oncol 2014;133:401–4
  6. Disaia JP, Creasman WT. Klinik Jinekolojik Onkoloji. Güneş yayınları. Çev Edt. Ali Ayhan. Adneksiyal Kitle ve Erken Ovarian Kanser 2003. p.260–3
  7. Sandri MT, Bottari F, Franchi D, Boveri S, Candiani M, Ronzoni S, et al. Comparison of HE4, CA125 and ROMA algorithm in women with a pelvic mass: Correlation with pathological outcome. Gynecol Oncol 2013;128:233–8
  8. Berek JS, Friedlander M, Hacker NF. Ephitelial ovarian, fallopian tube and peritoneal cancer. In: Berek JS, Friedlander M, Hacker NF, editors. Berek and Hacker’s gynecologic oncology. 5th ed. Philadelphia, PA: Lippincott Williams&Wilkins; 2009. p.443–508
  9. Fathalla MF. Incessant ovulation--a factor in ovarian neoplasia? Lancet 1971;2:163
  10. Guraslan H, Şentürk MB, Yaşar L. Calculation of risk of malignancy index in our clinic. Dicle Med J 2017;4:151–8 11. Vine MF, Calingaert B, Berchuck A, Schildkraut JM. Characterization of prediagnostic symptoms among primary epithelial ovarian cancer cases and controls. Gynecol Oncol 2003;90:75–82. 12. van Nagell JR, DePriest PD. Management of adnexal masses in postmenopausal women. Am J Obstet Gynecol 2005;193:30–5
  11. Purdie DM, Bain CJ, Siskind V, Webb PM, Green AC. Ovulation and risk of epithelial ovarian cancer. Int J Cancer 2003;104:228–32
  12. Bosetti C, Negri E, Trichopoulos D, Franceschi S, Beral V, Tzonou A, et al. Long-term effects of oral contraceptives on ovarian cancer risk. Int J Cancer 2002;102:262–5
  13. DePriest PD, Varner E, Powell J, Fried A, Puls L, Higgins R, et al. The efficacy of a sonographic morphology index in identifying ovarian cancer: A multi-institutional investigation. Gynecol Oncol 1994;55:174–8
  14. Timmerman D, Testa AC, Bourne T, Ferrazzi E, Ameye L, Ko